» Authors » Henry Mayala

Henry Mayala

Explore the profile of Henry Mayala including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 47
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fundikira L, Chillo P, Alimohamed M, Mayala H, Kifai E, Aloyce G, et al.
Glob Heart . 2024 Mar; 19(1):26. PMID: 38434152
Background: Non-ischemic dilated cardiomyopathy (NIDCM) is a common cause of heart failure with progressive tendency. The disease occurs in one in every 2,500 individuals in the developed world, with high...
2.
Mutagaywa R, Kifai E, Elinisa M, Mayala H, Kisenge P, Shemu T, et al.
Eur J Clin Invest . 2023 Oct; 54(3):e14114. PMID: 37874538
Background: Rheumatic heart disease remains the most common cardiovascular disease in children and young adults. The outcome of interventional versus medical therapy on the long term is not fully elucidated...
3.
Paulo D, Mutagaywa R, Mayala H, Barongo A
BMC Womens Health . 2023 Aug; 23(1):404. PMID: 37653369
Background: Rheumatic heart disease (RHD) remains prevalent in the developing world and reproductive-age women are disproportionately affected. It is among the common est cardiac diseases during pregnancy and is associated...
4.
Mutagaywa R, Cramer M, Chillo P, Barongo A, Kifai E, Chamuleau S, et al.
Cardiovasc J Afr . 2023 Feb; 35(1):16-26. PMID: 36745007
Background: For rheumatic mitral stenosis (MS), a multidisciplinary evaluation is mandatory to determine the optimal treatment: medical, percutaneous balloon mitral valvuloplasty (PBMV) or valve surgery. Clinical and imaging evaluations are...
5.
Pallangyo P, Komba M, Mkojera Z, Kisenge P, Bhalia S, Mayala H, et al.
Integr Blood Press Control . 2022 Aug; 15:97-112. PMID: 35991354
Background: Notwithstanding the availability of effective treatments, asymptomatic nature and the interminable treatment length, adherence to medication remains a substantial challenge among patients with hypertension. Suboptimal adherence to BP-lowering agents...
6.
Pallangyo P, Kweka G, Lyimo F, Mayala H, Swai H, Mkojera Z, et al.
J Med Case Rep . 2022 Feb; 16(1):77. PMID: 35144678
Introduction: Notwithstanding the diagnostic and therapeutic advancements, the incidence of cardiac metastases has increased in recent decades. Lung cancers are the most common primary malignant neoplasms with cardiac metastasis potential....
7.
Mafuru M, Wu S, Mayala H, Msengwa Z, Phillip A, Mgone C
Pharmgenomics Pers Med . 2021 Nov; 14:1379-1389. PMID: 34754219
Purpose: To analyze the combined effect of CYP2C19 genetic polymorphism and PPIs coadministration on voriconazole trough concentration (VCZ-C) in Chinese patients with hematological disorders. Patients And Methods: A prospective observational...
8.
Pallangyo P, Mkojera Z, Komba M, Mgopa L, Bhalia S, Mayala H, et al.
BMC Neurol . 2021 Nov; 21(1):433. PMID: 34749692
Background: The evolution of cognitive impairment of vascular origin is increasingly becoming a prominent health threat particularly in this era where hypertension is the leading contributor of global disease burden...
9.
Pallangyo P, Misidai N, Komba M, Mkojera Z, Swai H, Hemed N, et al.
BMC Cardiovasc Disord . 2020 Aug; 20(1):364. PMID: 32778068
Background: Health literacy on cardiovascular diseases (CVDs) plays an effective role in preventing or delaying the disease onset as well as in impacting the efficacy of their management. In view...
10.
Pallangyo P, Nicholaus P, Mayala H, Kabeho A, Nkinda A, Janabi M
J Med Case Rep . 2017 Oct; 11(1):301. PMID: 29070083
Background: Globally, over 36 million people were infected with human immunodeficiency virus by the end of 2015. The Sub-Saharan African region home to less than one-fifth of the global population...